These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3592633)

  • 41. Establishment and characterization of cell lines from the Walker carcinoma 256 able to grow in suspension culture and deficient in thymidine kinase.
    Arvelo F; Yabrudi A; Delgado ME; González-Cadavid N
    In Vitro; 1984 Jul; 20(7):549-65. PubMed ID: 6469274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 43. Sequential chromosome analysis of Walker carcinosarcoma-256 implanted into rats after frozen storage.
    Kajino G; Murase T; Amo H
    Cryobiology; 1974 Dec; 11(6):500-7. PubMed ID: 4452282
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative antitumour and haematological effects of some bifunctional alkylating agents containing mixed functional groups.
    Tisdale MJ; Elson LA; Ross WC
    Eur J Cancer (1965); 1973 Feb; 9(2):89-97. PubMed ID: 4717491
    [No Abstract]   [Full Text] [Related]  

  • 46. Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
    Elson LA
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):51-9. PubMed ID: 5659736
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chromosome studies on in vivo and in vitro grown Walker carcinoma 256].
    Wieser O; Kinzel V; Mohr U
    Z Krebsforsch; 1968; 71(2):124-8. PubMed ID: 4233459
    [No Abstract]   [Full Text] [Related]  

  • 48. The metabolism of chlorambucil.
    McLean A; Newell D; Baker G; Connors T
    Biochem Pharmacol; 1980 Jul; 29(14):2039-47. PubMed ID: 7406916
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapeutic activity and pathological effects of an alkylating agent of short half-life designed for intra-arterial infusion (CB 1850).
    Cobb LM
    Int J Cancer; 1967 Jan; 2(1):5-11. PubMed ID: 6036066
    [No Abstract]   [Full Text] [Related]  

  • 50. The toxicity and anti-tumour action of some alkylating sulphonamides.
    Hawkins R; Owen LN; Danielli JF
    J Theor Biol; 1963 Sep; 5(2):236-48. PubMed ID: 5875390
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.
    Lewis KM; Harford-Wright E; Vink R; Ghabriel MN
    Cancer Cell Int; 2013 Feb; 13(1):5. PubMed ID: 23374226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromosome variability in tumours and cell lines.
    Bengtsson BO
    Trends Ecol Evol; 1992 Jul; 7(7):241-2. PubMed ID: 21236018
    [No Abstract]   [Full Text] [Related]  

  • 53. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
    Tew KD; Wang AL
    Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards.
    Wang AL; Tew KD
    Cancer Treat Rep; 1985 Jun; 69(6):677-82. PubMed ID: 4016771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.
    Tew KD; Bomber AM; Hoffman SJ
    Cancer Res; 1988 Jul; 48(13):3622-5. PubMed ID: 3288331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired drug resistance is accompanied by modification in the karyotype and nuclear matrix of a rat carcinoma cell line.
    Tew KD; Moy BC; Hartley-Asp B
    Exp Cell Res; 1983 Dec; 149(2):443-50. PubMed ID: 6641811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-banding of two Walker 256 rat carcinoma cell lines sensitive and resistant to bifunctional mustards.
    Hartley-Asp B; Billström A; Tew KD
    Anticancer Res; 1987; 7(2):209-13. PubMed ID: 3592633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.
    Buller AL; Clapper ML; Tew KD
    Mol Pharmacol; 1987 Jun; 31(6):575-8. PubMed ID: 3600602
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.